细胞吸收剂报告称,2025年销售额将达到3710万美元,同比增长4%. Cytosorbents reports record 2025 sales of $37.1 million, up 4% year-over-year.

细胞吸收剂报告说,尽管德国销量下降了,2025年创纪录的3710万美元销售额增长4%. Cytosorbents reported record 2025 sales of $37.1 million, up 4% year-over-year, despite a decline in Germany. 该公司实现了430万美元的净利,并预计在2026年下半年将达到营运现金流平衡. The company achieved net income of $4.3 million and expects operating cash flow breakeven in the second half of 2026. 尽管FDA拒绝了De Novo提交的新产品,但该公司报告市场反很强,并继续扩大其国际存在. Although the FDA rejected a De Novo submission for a new product, the company reported strong market feedback and continues to expand its international presence.